Clinical trial
Biomarkers and Response to Natalizumab for Multiple Sclerosis Treatment
NCT00942214
Study timeline
Study start (unknown)2009-06-01Date precision: month
Registry last updated2011-03-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Interventions
NatalizumabDRUG · verified · RxNorm: natalizumab
Sponsors & collaborators
University Hospital, Toulouselead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00942214 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.